Fig. 6

In vivo efficacy of the C-T@Ti₃C₂ nanosheets in the treatment of wound infection. a Schematic diagram of the creation of the wound infection model, treatment approach and the different timelines following treatment. b Representative digital photos of the MRSA-infected wounds treated with nonmaterial (control), US only, C-T@Ti₃C₂, and C-T@Ti₃C₂ + US on Days 0, 1, 3, 5, 7, 9 and 11. Statistics of c body weight and d wound area for each group of mice recorded after different treatments (n = 5). e Histological staining (H&E, Masson, and CD 31 immunohistochemical staining) of the representative wounds was performed from different groups after 11 days. Statistical significance was calculated using the two-tailed t test, ^*P < 0.05, ^**P < 0.01, ^***P < 0.001